OPCH vs ZTS: fair value comparison
Option Care Health, Inc. and Zoetis Inc. · Updated 2026-09-07
Both currently screen as undervalued on TickrTrends' Forward Fair Value model. Within Healthcare, ZTS currently sits closer to the top of our discount ranking.
| OPCH | ZTS | |
|---|---|---|
| Verdict | Undervalued | Undervalued |
| Last price | $23.70 | $75.81 |
| 12-month range | $20.03–$34.61 | $77.10–$144.35 |
| Sector rank | #8 of 113 Healthcare | #5 of 113 Healthcare |
| Quality grade | C | C |
| Leverage | Low | Moderate |
| Margin trend | Contracting | Expanding |
| Revenue growth | Strong | Modest |
| RSI zone | Neutral | Neutral |
| 50/200-day trend | Mixed | — |
| DCF cross-check | Undervalued | Undervalued |
| 52-week position | The lower-middle quarter | The bottom quarter |
Full single-stock breakdowns: OPCH fair value analysis · ZTS fair value analysis